Article
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate…
medRxiv · 2021 · Clark, N. M.; Janaka, S. K.; Hartman, W.; Stramer, S.; Goodhue, E.; Weiss, J.; Evans, D. T.; Connor, J. P.
Key facts
| Title | Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infection. |
|---|---|
| First author | Clark, N. M.; Janaka, S. K.; Hartman, W.; Stramer, S.; Goodhue, E.; Weiss, J.; Evans, D. T.; Connor, J. P. |
| Journal | medRxiv |
| Published | Sep 17, 2021 |
| DOI | 10.1101/2021.09.14.460394 |
| Devices mentioned | DEN210038, DEN210040, K001266, K001310, K001679, K001769, K001885, K003112, K011250, K011463, K012561, K012593 and 133 more |
| Product codes mentioned | CDD, CDN, CDP, CDT, CDZ, CEC, CEK, CEM, CEO, CEP, CEW, CFJ and 121 more |
At a glance
- 100–999 FDA submissions mentioned
- 100–999 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1